The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity

Journal of Clinical Investigation

Volumn 114, Issue 5, 2004, Pages 701-712

  Bowen, David G ^a,b   Zen, Monica ^a   Holz, Lauren ^a   Davis, Thomas ^a   McCaughan, Geoffrey W ^a   Bertolino, Patrick ^a  

^a CENTENARY INSTITUTE   (Australia)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; IMMUNOLOGICAL ADJUVANT; L SELECTIN; MONOCLONAL ANTIBODY;

ANIMAL CELL; ARTICLE; CHRONIC HEPATITIS; GRAFT REJECTION; HALF LIFE TIME; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LIVER CELL DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; ANIMAL; CD8+ T LYMPHOCYTE; HEPATITIS; IMMUNOLOGY; LIVER; LYMPH NODE; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS; IMMUNE TOLERANCE; L-SELECTIN; LIVER; LYMPH NODES; MICE; T-LYMPHOCYTES;

EID: 4944245002     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200421593     Document Type: Article

References (52)

1. Bertolino, P., Glimpel, G., and Lemon, S.M. 2000. Hepatic inflammation and immunity: a summary of a conference on the function of the immune system within the liver. Hepatology. 31:1374-1378.
2. Crispe, I.N. 2003, Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 3:51-62.
3. Calne, R.Y., et al. 1969. Induction of immunological tolerance by porcine liver allografts. Nature. 223:472-476.
4. Qian, S., et al. 1994. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 19:916-924.
5. Sun, J., McCaughan, G.W., Gallagher, N.D., Sheil, A.G., and Bishop, G.A. 1995. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation. 60:233-236.
6. Kamada, N., Brons, G., and Davies, H.S. 1980. Fully allogeneic liver grafting in rats induces a state of systemic nonreactivity to donor transplantation antigens. Transplantation. 29:429-431.
7. Gallery, M.P., Kamei, T., and Flye, M.W. 1989. The effect of portacaval shunt on delayed-hypersensitivity responses following antigen feeding. J. Surg. Res. 46:391-394.
8. Kita, H., Mackay, I.R., Van De Water, J., and Gershwin, M.E. 2001. The lymphoid liver: considerations on pathways to autoimmune injury. Gastroenterology. 120:1485-1501.
9. Vierling, J.M. 1992. Immune disorders of the liver and bile duct. Gastroenterol. Clin. North Am. 21:427-449.
10. Chisari, F.V., and Ferrari, C. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
11. Cerny, A., and Chisari, F.V. 1999. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology. 30:595-601.
12. Ando, K., Guidotti, L.G., Cerny, A., Ishikawa, T., and Chisari, F.V. 1994. CTL access to tissue antigen is restricted in vivo. J. Immunol. 153:482-488.
13. Huang, L., Soldevila, G., Leeker, M., Flavell, R., and Crispe, I.N. 1994. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity. 1:741-749.
14. Mehal, W.Z., Juedes, A.E., and Crispe, I.N. 1999. Selective retention of activated CD8+ T cells by the normal liver. J. Immunol. 163:3202-3210.
15. Hamann, A., Klugewitz, K., Austrup, P., and Jablonski-Westrich, D. 2000. Activation induces rapid and profound alterations in the trafficking of T cells. Eur. J. Immunol. 30:3207-3218.
16. Bertolino, P., Bowen, D.G., McCaughan, G.W., and Fazekas De St Groth, B. 2001. Antigen-specific primary activation of CD8+ T cells within the liver. J. Immunol. 166:5430-5438.
17. Bowen, D.G., et al. 2002. Cytokine-dependent bystander hepatitis due to intrahepatic murine CD8+ T-cell activation by bone marrow-derived cells. Gastroenterology. 123:1252-1264.
18. Mackay, C.R., Marston, W.L., and Dudler, L. 1990. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171:801-817.
19. MacSween, R.N.M., and Scothorne, R.J. 1979. Developmental anatomy and normal structure. In Pathology of the liver. R.N.M. MacSween, P.P. Anthony, and P.J. Scheuer, editors. Churchill Livingstone. New York, New York, USA. 1-49.
20. Bertolino, P., McCaughan, G.W., and Bowen, D.G. 2002. Role of primary intrahepatic T-cell activation in the 'liver tolerance effect.' Immunol. Cell Biol. 80:84-92.
21. Bertolino, P., Trescol-Biemont, M.C., and Rabourdin-Combe, C. 1998. Hepatocytes induce functional activation of naive CD8+ T lymphocytes but fail to promote survival. Eur. J. Immunol. 28:221-236.
22. Bertolino, P., et al. 1999. Death by neglect as a deletional mechanism of peripheral tolerance. Int. Immunol. 11:1225-1238.
23. Schönrich, G., et al. 1992. Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int. Immunol. 4:581-590.
24. Limmer, A., et al. 1998. Failure to induce organ-specific autoimmunity by breaking of tolerance: importance of the microenvironment. Eur. J. Immunol. 28:2395-2406.
25. Morahan, G., et al. 1989. Expression in transgenic mice of class I histocompatibility antigens controlled by the metallothionein promoter. Proc. Natl. Acad. Sci. U. S. A. 86:3782-3786.
26. Bertolino, P., Heath, W.R., Hardy, C.L., Morahan, G., and Miller, J.F. 1995. Peripheral deletion of autoreactive CD8+ T cells in transgenic mice expressing H-2Kb in the liver. Eur. J. Immunol. 25:1932-1942.
27. Schönrich, G., et al. 1991. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell. 65:293-304.
28. Heath, W.R., and Miller, J.F. 1993. Expression of two alpha chains on the surface of T cells in T cell receptor transgenic mice. J. Exp. Med. 178:1807-1811.
29. Girard, J.P., and Springer, T.A. 1995. High endothelial venules (HEVs): specialized endothelium for lymphocyte migration. Immunol. Today. 16:449-457.
30. Chao, C.C., Jensen, R., and Dailey, M.O. 1997. Mechanisms of L-selectin regulation by activated T cells. J. Immunol. 159:1686-1694.
31. Dawson, J., Sedgwick, A.D., Edwards, J.C., and Lees, P. 1992. The monoclonal antibody MEL-14 can block lymphocyte migration into a site of chronic inflammation. Eur. J. Immunol. 22:1647-1650.
32. Lepault, F., Gagnerault, M.C., Faveeuw, C., and Boitard, C. 1994. Recirculation, phenotype and functions of lymphocytes in mice treated with monoclonal antibody MEL-14. Eur. J. Immunol. 24:3106-3112.
33. Tripp, R.A., Topham, D.J., Watson, S.R., and Doherty, P.C. 1997. Bone marrow can function as a lymphoid organ during a primary immune response under conditions of disrupted lymphocyte trafficking. J. Immunol. 158:3716-3720.
34. Hou, S., Hyland, L., Bradley, L.M., Watson, S.R., and Doherty, P.C. 1995. Subverting lymph node trafficking by treatment with the Mel-14 monoclonal antibody to L-selectin does not prevent an effective host response to Sendai virus. J. Immunol. 155:252-258.
35. Harrington, L.E., Galvan, M., Baum, L.G., Altman, J.D., and Ahmed, R. 2000. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J. Exp. Med. 191:1241-1246.
36. Guerder, S., Rincon, M., and Schmitt-Verhulst, A.M. 2001. Regulation of activator protein-1 and NF-kappa B in CD8+ T cells exposed to peripheral self-antigens. J. Immunol. 166:4399-4407.
37. Fazekas de St Groth, B., et al. 1999. Carboxyfluorescein diacetate succinimidyl ester and the virgin lymphocyte: a marriage made in heaven. Immunol. Cell Biol. 77:530-538.
38. Kaech, S.M., and Ahmed, R. 2001. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2:415-422.
39. Lakkis, F.G., Arakelov, A., Konieczny, B.T., and Inoue, Y. 2000. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat. Med. 6:686-688.
40. Gagnerault, M.C., Luan, J.J., Lotton, C., and Lepault, F. 2002. Pancreatic lymph nodes are requited for priming of beta cell reactive T cells in NOD mice. J. Exp. Med. 196:369-377.
41. Chin, R., Zhou, P., Alegre, M.L., and Fu, Y.X. 2001. Confounding factors complicate conclusions in aly model. Nat. Med. 7:1165-1166.
42. Feuerer, M., et al. 2003. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat. Med. 9:1151-1157.
43. Willberg, C., Barnes, E., and Klenerman, P. 2003. HCV immunology: death and the maiden T cell. Cell Death Differ. 10(Suppl. 1):S39-S47.
44. Gruener, N.H., et al. 2001. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J. Virol. 75:5550-5558.
45. Wedemeyer, H., et al. 2002. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J. Immunol. 169:3447-3458.
46. Missale, G., et al. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest. 98:706-714.
47. Qian, S., et al. 1997. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J. Immunol. 158:4654-4661.
48. Sharland, A., et al. 1999. Evidence that apoptosis of activated T cells occurs in spontaneous tolerance of livet allografts and is blocked by manipulations which break tolerance. Transplantation. 68:1736-1745.
49. Starzl, T.E., et al. 1992. Cell migration, chimerism, and graft acceptance. Lancet. 339:1579-1582.
50. Bishop, G.A., Sun, J., Sheil, R., and McCaughan, G.W. 1997. High dose/activation-associated tolerance. A mechanism for allograft tolerance. Transplantation. 64:1377-1382.
51. Reeves, J.P., Reeves, P.A., and Chin, L.T. 1991. Survival surgery: removal of the spleen or thymus. In Current protocols in immunology. J.E. Coligan, A.M. Kruisbeek, D.H. Margulies, E.M. Shevach, and W. Strober, editors. John Wiley & Sons Inc. New York, New York, USA. 1.10.11-11.10.11.
52. Klugewitz, K., et al. 2002. Immunomodulatory effects of the liver: deletion of activated CD4(+) effector cells and suppression of IFN-gamma-producing cells after intravenous protein immunization. J. Immunol. 169:2407-2413.